Clinical Trial Update: Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating OMT-28 for maintaining sinus rhythm in patients with persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• OMT-28

Snippet

Sponsor: Omeicos Therapeutics GmbH | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED